| Product Name | 3β-17-Imino-androst-5-en-3-ol dimer |
| Product Code | DA-A007-07 |
| Chemical name | 3β-17-Imino-androst-5-en-3-ol dimer |
| Synonyms | (3S,3'S,8R,8'R,9S,9'S,10R,10'R,13S,13'S,14S,14'S,17E,17'E)-17,17'-(Hydrazine-1,2-diylidene)bis(10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol);androst-5-en-17-one, 3-hydroxy-, [(3B)-3-hydroxyandrost-5-en-17-ylidene]hydrazone, (3B)- (9CI); |
| Impurity | NA |
| CAS Number | 491873-45-1 |
| Alternate CAS # | NA |
| Molecular form | C38H56N2O2 |
| Appearance | White to Off-White Solid |
| Melting Point | NA |
| Mol. Weight | 572.88 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,fine chemicals |
| Boiling Point | NA |
| Applications | 3β-17-Imino-androst-5-en-3-ol Dimer is an impurity of Abiraterone, a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor. Abiraterone is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
| NA |
